Role of soluble epoxide hydrolase in age-related vascular cognitive decline

Jonathan W. Nelson, Jennifer M. Young, Rohan N. Borkar, Randall (Randy) Woltjer, Joseph Quinn, Lisa Silbert, Marjorie Grafe, Nabil Alkayed

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

P450 eicosanoids are important regulators of the cerebral microcirculation, but their role in cerebral small vessel disease is unclear. We tested the hypothesis that vascular cognitive impairment (VCI) is linked to reduced cerebral microvascular eicosanoid signaling. We analyzed human brain tissue from individuals formerly enrolled in the Oregon Brain Aging Study, who had a history of cognitive impairment histopathological evidence of microvascular disease. VCI subjects had significantly higher lesion burden both on premortem MRI and postmortem histopathology compared to age- and sex-matched controls. Mass spectrometry-based eicosanoid analysis revealed that 14,15-dihydroxyeicosatrienoic acid (DHET) was elevated in cortical brain tissue from VCI subjects. Immunoreactivity of soluble epoxide hydrolase (sEH), the enzyme responsible for 14,15-DHET formation, was localized to cerebral microvascular endothelium, and was enhanced in microvessels of affected tissue. Finally, we evaluated the genotype frequency of two functional single nucleotide polymorphisms of sEH gene EPHX2 in VCI and control groups. Our findings support a role for sEH and a potential benefit from sEH inhibitors in age-related VCI.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalProstaglandins and Other Lipid Mediators
Volume113-115
DOIs
StatePublished - Sep 30 2014

Fingerprint

Epoxide Hydrolases
Blood Vessels
Eicosanoids
Brain
Tissue
Microcirculation
Cerebral Small Vessel Diseases
Polymorphism
Magnetic resonance imaging
Mass spectrometry
Nucleotides
Genes
Aging of materials
Microvessels
Endothelium
Single Nucleotide Polymorphism
Cognitive Dysfunction
Mass Spectrometry
Enzymes
Genotype

Keywords

  • EETs
  • EPHX2
  • Epoxyeicosatrienoic acids
  • Soluble epoxide hydrolase
  • Vascular cognitive impairment
  • White matter hyperintensity

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Role of soluble epoxide hydrolase in age-related vascular cognitive decline. / Nelson, Jonathan W.; Young, Jennifer M.; Borkar, Rohan N.; Woltjer, Randall (Randy); Quinn, Joseph; Silbert, Lisa; Grafe, Marjorie; Alkayed, Nabil.

In: Prostaglandins and Other Lipid Mediators, Vol. 113-115, 30.09.2014, p. 30-37.

Research output: Contribution to journalArticle

@article{6428ab57cd8449c2b2e80d58c16c9756,
title = "Role of soluble epoxide hydrolase in age-related vascular cognitive decline",
abstract = "P450 eicosanoids are important regulators of the cerebral microcirculation, but their role in cerebral small vessel disease is unclear. We tested the hypothesis that vascular cognitive impairment (VCI) is linked to reduced cerebral microvascular eicosanoid signaling. We analyzed human brain tissue from individuals formerly enrolled in the Oregon Brain Aging Study, who had a history of cognitive impairment histopathological evidence of microvascular disease. VCI subjects had significantly higher lesion burden both on premortem MRI and postmortem histopathology compared to age- and sex-matched controls. Mass spectrometry-based eicosanoid analysis revealed that 14,15-dihydroxyeicosatrienoic acid (DHET) was elevated in cortical brain tissue from VCI subjects. Immunoreactivity of soluble epoxide hydrolase (sEH), the enzyme responsible for 14,15-DHET formation, was localized to cerebral microvascular endothelium, and was enhanced in microvessels of affected tissue. Finally, we evaluated the genotype frequency of two functional single nucleotide polymorphisms of sEH gene EPHX2 in VCI and control groups. Our findings support a role for sEH and a potential benefit from sEH inhibitors in age-related VCI.",
keywords = "EETs, EPHX2, Epoxyeicosatrienoic acids, Soluble epoxide hydrolase, Vascular cognitive impairment, White matter hyperintensity",
author = "Nelson, {Jonathan W.} and Young, {Jennifer M.} and Borkar, {Rohan N.} and Woltjer, {Randall (Randy)} and Joseph Quinn and Lisa Silbert and Marjorie Grafe and Nabil Alkayed",
year = "2014",
month = "9",
day = "30",
doi = "10.1016/j.prostaglandins.2014.09.003",
language = "English (US)",
volume = "113-115",
pages = "30--37",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Role of soluble epoxide hydrolase in age-related vascular cognitive decline

AU - Nelson, Jonathan W.

AU - Young, Jennifer M.

AU - Borkar, Rohan N.

AU - Woltjer, Randall (Randy)

AU - Quinn, Joseph

AU - Silbert, Lisa

AU - Grafe, Marjorie

AU - Alkayed, Nabil

PY - 2014/9/30

Y1 - 2014/9/30

N2 - P450 eicosanoids are important regulators of the cerebral microcirculation, but their role in cerebral small vessel disease is unclear. We tested the hypothesis that vascular cognitive impairment (VCI) is linked to reduced cerebral microvascular eicosanoid signaling. We analyzed human brain tissue from individuals formerly enrolled in the Oregon Brain Aging Study, who had a history of cognitive impairment histopathological evidence of microvascular disease. VCI subjects had significantly higher lesion burden both on premortem MRI and postmortem histopathology compared to age- and sex-matched controls. Mass spectrometry-based eicosanoid analysis revealed that 14,15-dihydroxyeicosatrienoic acid (DHET) was elevated in cortical brain tissue from VCI subjects. Immunoreactivity of soluble epoxide hydrolase (sEH), the enzyme responsible for 14,15-DHET formation, was localized to cerebral microvascular endothelium, and was enhanced in microvessels of affected tissue. Finally, we evaluated the genotype frequency of two functional single nucleotide polymorphisms of sEH gene EPHX2 in VCI and control groups. Our findings support a role for sEH and a potential benefit from sEH inhibitors in age-related VCI.

AB - P450 eicosanoids are important regulators of the cerebral microcirculation, but their role in cerebral small vessel disease is unclear. We tested the hypothesis that vascular cognitive impairment (VCI) is linked to reduced cerebral microvascular eicosanoid signaling. We analyzed human brain tissue from individuals formerly enrolled in the Oregon Brain Aging Study, who had a history of cognitive impairment histopathological evidence of microvascular disease. VCI subjects had significantly higher lesion burden both on premortem MRI and postmortem histopathology compared to age- and sex-matched controls. Mass spectrometry-based eicosanoid analysis revealed that 14,15-dihydroxyeicosatrienoic acid (DHET) was elevated in cortical brain tissue from VCI subjects. Immunoreactivity of soluble epoxide hydrolase (sEH), the enzyme responsible for 14,15-DHET formation, was localized to cerebral microvascular endothelium, and was enhanced in microvessels of affected tissue. Finally, we evaluated the genotype frequency of two functional single nucleotide polymorphisms of sEH gene EPHX2 in VCI and control groups. Our findings support a role for sEH and a potential benefit from sEH inhibitors in age-related VCI.

KW - EETs

KW - EPHX2

KW - Epoxyeicosatrienoic acids

KW - Soluble epoxide hydrolase

KW - Vascular cognitive impairment

KW - White matter hyperintensity

UR - http://www.scopus.com/inward/record.url?scp=84910018436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910018436&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2014.09.003

DO - 10.1016/j.prostaglandins.2014.09.003

M3 - Article

C2 - 25277097

AN - SCOPUS:84910018436

VL - 113-115

SP - 30

EP - 37

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

ER -